References
- 1
Ahlsen G, Rosengren L, Belfrage M, Palm A, Haglid K, Hamberger A. et al .
Glial fibrillary acidic protein in the cerebrospinal fluid of children with autism
and other neuropsychiatric disorders.
Biol Psychiatry.
1993;
10
734-743
- 2
Arend A O, Leary P M, Rutherfoord G S.
Alexander's disease: A case report with brain biopsy, ultrasound, CT scan and MRI
findings.
Clin Neuropathol.
1991;
3
122-126
- 3
Blennow M, Hagberg H, Rosengren L.
Glial fibrillary acidic protein in the cerebrospinal fluid: A possible indicator of
prognosis in full-term asphyxiated newborn infants?.
Pediatr Res.
1995;
3
260-264
- 4 Duchen L W.
General pathology of neurons and neuroglia. Adams JH, Corsellis JAN, Duchen LW Greenfield's Neuropathology. London; Edward Arnold
1984: 1-52
- 5
Ehlers S, Kyllerman M, Rosengren L.
Analysis of glial fibrillary acidic protein in the cerebrospinal fluid of children
investigated for encephalopathy.
Neuropediatrics.
1994;
3
129-133
- 6
Holmberg B, Rosengren L, Karlsson J E, Johnels B.
Increased cerebrospinal fluid levels of neurofilament protein in progressive supranuclear
palsy and multiple-system atrophy compared with Parkinson's disease.
Mov Disord.
1998;
1
70-77
- 7
Kristjánsdóttir R, Uvebrant P, Hagberg B, Kyllerman M, Wiklund L M, Blennow G. et
al .
Disorders of the cerebral white matter in children. The spectrum of lesions.
Neuropediatrics.
1996;
6
295-298
- 8
Kristjánsdóttir R, Uvebrant P, Wiklund L M.
Clinical characteristics of children with cerebral white matter abnormalities.
Europ J Paediatr Neurol.
2000;
1
17-26
- 9
Kristjánsdóttir R, Uvebrant P, Lekman A, Månsson J-E.
Cerebrospinal fluid markers in children with cerebral white matter abnormalities.
Neuropediatrics.
2001;
32
176-182
- 10
Lycke J N, Karlsson J E, Andersen O, Rosengren L E.
Neurofilament protein in cerebrospinal fluid: a potential marker of activity in multiple
sclerosis.
J Neurol Neurosurg Psychiatry.
1998;
3
402-404
- 11 Månsson J-E, Fredman P.
White matter neurochemistry: Normal and pathological states. Pantoni L, Inzitari D, Wallin A “The Matter of White Matter”: Clinical and Pathophysiological
Aspects of White Matter Disease Related to Cognitive Decline and Vascular Dementia. The
Netherlands; Academic Pharmaceutical Production 2000: 275-286
- 12
Rosengren L E, Ahlsen G, Belfrage M, Gillberg C, Haglid K G, Hamberger A.
A sensitive ELISA for glial fibrillary acidic protein: Application in CSF of children.
J Neurosci Methods.
1992;
2 - 3
113-119
- 13
Rosengren L E, Karlsson J E, Karlsson J O, Persson L I, Wikkelso C.
Patients with amyotrophic lateral sclerosis and other neurodegenerative diseases have
increased levels of neurofilament protein in CSF.
J Neurochem.
1996;
5
2013-2018
- 14
Rosengren L E, Karlsson J E, Sjogren M, Blennow K, Wallin A.
Neurofilament protein levels in CSF are increased in dementia.
Neurology.
1999;
5
1090-1093
- 15
Tullberg M, Rosengren L, Blomsterwall E, Karlsson J E, Wikkelso C.
CSF neurofilament and glial fibrillary acidic protein in normal pressure hydrocephalus.
Neurology.
1998;
4
1122-1127
- 16
Varho T, Jaaskelainen S, Tolonen U, Sonninen P, Vainionpaa L, Aula P. et al .
Central and peripheral nervous system dysfunction in the clinical variation of Salla
disease.
Neurology.
2000;
1
99-104
Prof. Paul Uvebrant
Department of Paediatrics, The Queen Silvia Children's Hospital/SU, Göteborg University
416 85 Göteborg
Sweden
Email: paul.uvebrant@pediat.gu.se
